ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 26 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $292,000 | +17.7% | 132,600 | 0.0% | 0.01% | +40.0% |
| Q1 2022 | $248,000 | +2.9% | 132,600 | +20.5% | 0.01% | +25.0% |
| Q4 2021 | $241,000 | -34.3% | 110,000 | 0.0% | 0.00% | -42.9% |
| Q3 2021 | $367,000 | +24.8% | 110,000 | 0.0% | 0.01% | +40.0% |
| Q2 2021 | $294,000 | +14.4% | 110,000 | -8.3% | 0.01% | 0.0% |
| Q1 2021 | $257,000 | -13.2% | 120,000 | 0.0% | 0.01% | -16.7% |
| Q4 2020 | $296,000 | +107.0% | 120,000 | +71.4% | 0.01% | +100.0% |
| Q3 2020 | $143,000 | -30.9% | 70,000 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $207,000 | +132.6% | 70,000 | +100.0% | 0.00% | +100.0% |
| Q1 2020 | $89,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,349,953 | $8,046,000 | 2.52% |
| Novo Holdings A/S | 2,181,843 | $13,004,000 | 2.23% |
| Sofinnova Investments, Inc. | 1,180,178 | $7,034,000 | 0.64% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,041,496 | $12,168,000 | 0.09% |
| Eventide Asset Management | 392,513 | $2,288,000 | 0.08% |
| Blackstone Inc. | 1,623,405 | $9,675,000 | 0.06% |
| Granahan Investment Management | 141,012 | $840,000 | 0.05% |
| Janney Montgomery Scott LLC | 46,861 | $279,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 5,921 | $35,000 | 0.00% |
| BlackRock Inc. | 15,755 | $94,000 | 0.00% |